Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

307

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

307 results for “cardiovascular risk factors”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.

ClinicalTrials.gov study NCT00186537. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
dryad36/100

Assessment of cardiovascular risk factors in patients with Knee Osteoarthritis

Open the record for dataset details and reuse information.

publicJun 2021View details →
dryad36/100

Risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry

Open the record for dataset details and reuse information.

publicMar 2020View details →
dryad36/100

Associations of serum uric acid with cardiovascular disease risk factors: a retrospective cohort study in Southeastern China

Open the record for dataset details and reuse information.

publicAug 2023View details →
dryad32/100

Systematic review data of whole grains versus placebo or refined grains on cardiovascular disease risk factors.

<p class="Body"><span>This dataset comprises data extracted 29 publications which were included in a systematic review and meta-analysis of randomised controlled trials which compared whole grain versus refined grain dietary intake on cardiovascular disease risk factors. There were 80 cardiovascular disease risk factor outcome measures considered in the review. Data were extracted by one investigator and checked for accuracy twice. Study characteristics were extracted, including study design, sample population, and details of the intervention and control conditions. Outcome data were extracted for the intervention and comparator groups were baseline, change, and follow-up variables, variable units, and statistical significance over time and between groups. Adverse events were also recorded. The 29 included studies measured and reported on 40 outcomes. Extracted outcomes can be grouped as haemodynamics (reported by 12 studies), body composition (15 studies), blood lipids (18 studies), glycaemic and/or insulin markers (19 studies), inflammatory markers (21 studies), oxidative stress markers (6 studies), and cardiovascular comorbidity incidence (2 studies). Rigorous analysis, including meta-regression, may be carried out using this data to evaluate the cause and effect relationship of whole grains on cardiovascular risk by considering confounding variables on pooled outcomes. </span></p>

opencc-zeroJul 2020View details →
dryad32/100

Modifiable cardiovascular risk factors in patients with sporadic cerebral cavernous malformations: obesity matters

Objective <p>To assess the influence of modifiable cardiovascular risk factors on hemorrhage risk of sporadic cerebral cavernous malformations (CCMs).</p> Methods <p>From 1219 consecutive CCM patients (2003-2018), adult subjects with sporadic CCM and complete MRI were included. We evaluated presence of intracerebral hemorrhage (ICH) as mode of presentation, occurrence of ICH during follow-up and risk factors arterial hypertension, diabetes mellitus, hyperlipidemia, nicotine abuse, and obesity (BMI&gt;30kg/m²). Impact of risk factors on ICH at presentation was calculated using univariate and multivariate logistic regression with age- and sex-adjustment. We performed Kaplan Meier and Cox regression to analyze cumulative 5-year-risk for (re-)bleeding. </p> Results <p>We included 682 CCM patients. The univariate logistic regression showed a significant relationship (OR=1.938, 95% CI: (1.120–3.353), p=0.018) between obesity and ICH as mode of presentation. Multivariate adjusted logistic regression confirmed significant correlation with OR=1.902 (95% CI: 1.024–3.532, p=0.042). Cox regression did not identify predictors for occurrence of (re-)hemorrhage (p&gt;0.05; Hazard ratios: arterial hypertension 1.112 (95% CI: 0.622–1.990), diabetes 0.850 (95% CI: 0.208–3.482), hyperlipidemia 0.719 (95% CI: 0.261–1.981), nicotine abuse 1.123 (95% CI: 0.591–2.134), and obesity 0.928 (95% CI: 0.416–2.070)). </p> Conclusions <p>This study provides evidence that obesity may be a risk factor for CCM hemorrhage. It was significantly associated with ICH as mode of presentation. Other risk factors (arterial hypertension, diabetes mellitus, hyperlipidemia and current nicotine abuse) showed no such effect. None of the factors showed to be independent predictors for cumulative 5-year-risk of (re-)bleeding.  </p>

opencc-zeroSep 2020View details →
ClinicalTrials.gov32/100

ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension

ClinicalTrials.gov study NCT06264622. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians

ClinicalTrials.gov study NCT00608387. IPD Sharing: Not stated. Countries: 1. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Cardiovascular Risk Factors in Overweight Adolescents

ClinicalTrials.gov study NCT00184236. IPD Sharing: NO. Countries: 1. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice

ClinicalTrials.gov study NCT00348855. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Cardiovascular Risk Factors and LCH in Adults

ClinicalTrials.gov study NCT00483925. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity

ClinicalTrials.gov study NCT00161174. IPD Sharing: Not stated. Countries: 1. Publications: 52.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

ClinicalTrials.gov study NCT03127631. IPD Sharing: NO. Countries: 7. Publications: 2.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Cardiovascular Risk Factor Management in HIV Infection

ClinicalTrials.gov study NCT00264394. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Effect of Trans Fatty Acids From Ruminant Sources on Risk Factors for Cardiovascular Disease

ClinicalTrials.gov study NCT00942656. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study

ClinicalTrials.gov study NCT04426084. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Cardiovascular Patients With no Standard Modifiable Risk Factors

ClinicalTrials.gov study NCT06199869. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke

ClinicalTrials.gov study NCT03710902. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Effects of Cocoa Products on Cardiovascular Disease Risk Factors

ClinicalTrials.gov study NCT00511420. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease

ClinicalTrials.gov study NCT02646488. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record